ValueAct Capital Partners → NTR
ValueAct Capital holds 1.5% of Nutrien Ltd..
SEC source
Frequently asked questions
What stake does ValueAct Capital Partners hold in NTR?
ValueAct Capital Partners (ValueAct Capital) holds 1.5% of Nutrien Ltd. (NTR) via 13D filed 2024-07-29. Initial filing date: 2024-07-29. Active campaign — fund publicly seeks operational or governance changes.
What is ValueAct Capital Partners's thesis for NTR?
Improve capital allocation, explore potash/nitrogen business separation. Constructive-activism posture typical of ValueAct.
What's the difference between 13D and 13G filings?
Both are filed when a fund crosses 5% ownership of a public company. SCHEDULE 13D = active intent (the fund plans to influence management, board, M&A, or capital allocation). SCHEDULE 13G = passive intent (long-term position, no active influence). 13D filings carry stricter disclosure (10-day window from purchase); 13G is for long-only managers + index funds. NTR filing type: 13D.
Where does HoldLens get activist filing data?
SEC EDGAR Schedule 13D and 13G filings (10-day disclosure window for 13D; 45-day initial window for 13G then amendments as positions change). HoldLens federates campaigns across tracked activist funds and computes stake-change deltas over time. See /methodology for the full source list.
Data sourced from SEC EDGAR 13D / 13G filings. Activist intent and outcome reflect public disclosures and announcements only. Not investment advice.
Reading for your research
Optional background reading on interpreting company disclosures and investing methods. These books do not validate a signal or predict returns.
Amazon affiliate links — as an Amazon Associate, HoldLens earns from qualifying purchases and membership trials at no extra cost to you. These are books we genuinely recommend. Not investment advice; always do your own research.